SCHEMBL369244

SCHEMBL369244

CCCCPc1ccc2ccccc2c1-c1c(OC(C)C)ccc2ccccc12

nearest known ligand 0.43

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2C9 P11712 3/20 0.43
MAPT P10636 2/20 0.43
CYP2C19 P33261 2/20 0.43
CYP1A2 P05177 1/20 0.43
GAA P10253 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NCEH1 Q6PIU2 2/20 0.34
HTR1B P28222 2/20 0.33
ALOX5 P09917 1/20 0.33
NR2E1 Q9Y466 1/20 0.33
CNR1 P21554 2/20 0.33
CNR2 P34972 2/20 0.33
KCNH2 Q12809 1/20 0.32
CYP3A4 P08684 1/20 0.32
IRAK4 Q9NWZ3 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3274613 0.79 MAPT (0.62) CYP2C9MAPTCYP2C19CYP1A2TDP1
SCHEMBL1933357 0.76 TLR8 (0.38) MAPTGAATDP1L3MBTL1HTR1B
SCHEMBL30456416 0.76 TLR8 (0.38) MAPTGAATDP1L3MBTL1HTR1B
SCHEMBL15076880 0.75 SLC2A1 (0.34) MAPTCYP2C19CYP1A2GAATDP1
SCHEMBL16241795 0.72 MAPT (0.54) CYP2C9MAPTCYP2C19CYP1A2TDP1
SCHEMBL19222664 0.71 MAPT (0.53) CYP2C9MAPTCYP2C19CYP1A2GAA
SCHEMBL30719117 0.70 MAPT (0.55) CYP2C9MAPTCYP2C19CYP1A2TDP1
SCHEMBL5387322 0.70 HTR1B (0.40) CYP2C9CYP2C19CYP1A2GAATDP1
SCHEMBL14232481 0.69 MAPT (0.54) CYP2C9MAPTCYP2C19CYP1A2L3MBTL1
SCHEMBL19328692 0.69 CA1 (0.38) MAPTCYP3A4IRAK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593439-A2 PROCESS FOR PREPARING ANTIVIRAL COMPOUNDS Abbvie Inc. (US) 2013-05-22 EP disclosed
WO-2012009699-A2 PROCESS FOR PREPARING ANTIVIRAL COMPOUNDS ABBOTT LABORATORIES (US) 2012-01-19 WO disclosed